Creating advanced tools for precise brain mapping
Recombinant Immunolabels for Nanoprecise Brain Mapping Across Scales
This study is working on creating special tools that help scientists see and understand the brain's complex connections better, so they can learn more about how the brain works and what happens when things go wrong, making these tools available for researchers to use in their studies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-10675062 on NIH RePORTER |
What this research studies
This research focuses on developing recombinant immunolabels that enhance the ability to map the brain's intricate circuitry with high precision. By utilizing a combination of techniques, the project aims to create a collection of monoclonal antibodies that can be miniaturized to nanoscale, allowing for detailed labeling of brain structures at the molecular level. This approach will improve imaging resolution and provide valuable insights into brain function and dysfunction. The ultimate goal is to make these high-quality antibodies widely available to neuroscience researchers for future studies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with neurological conditions that require advanced brain mapping techniques for diagnosis or treatment.
Not a fit: Patients with conditions unrelated to brain function or those who do not require detailed brain mapping may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in understanding brain circuitry, potentially improving treatments for neurological disorders.
How similar studies have performed: Other research has shown success in using advanced imaging techniques and monoclonal antibodies for brain mapping, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Murray, Karl Daniel — University of California at Davis
- Study coordinator: Murray, Karl Daniel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.